英夫利昔单抗治疗一名难治性回结肠型克罗恩病合并高安动脉炎患者。 - Suppr

Suppr

超能文献

Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.

作者信息

Calderón R, Estrada S, Ramírez de la Piscina P, Salvador M, Zabaleta S, Enciso C, Delgado E, García-Campos F

出版信息

Rev Esp Enferm Dig. 2010 Feb;102(2):145-6.

PMID:20361852

Abstract

摘要

相似文献

Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.

Rev Esp Enferm Dig. 2010 Feb;102(2):145-6.

Takayasu's aortitis and infliximab.

J Pediatr. 2009 Jul;155(1):151. doi: 10.1016/j.jpeds.2009.01.056.

[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].

Gastroenterol Hepatol. 2014 Jan;37(1):21-2. doi: 10.1016/j.gastrohep.2013.06.008. Epub 2013 Sep 9.

Refractory Takayasu arteritis successfully treated with infliximab.

Eur Rev Med Pharmacol Sci. 2009 Jan-Feb;13(1):63-5.

Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.

Intern Med. 2006;45(5):313-6. doi: 10.2169/internalmedicine.45.1377. Epub 2006 Apr 3.

Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.

Inflamm Bowel Dis. 2009 Oct;15(10):1458-9. doi: 10.1002/ibd.20965.

Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.

Inflamm Bowel Dis. 2009 Oct;15(10):1460-6. doi: 10.1002/ibd.20915.

[Infliximab-induced hepatitis in a patient with Crohn's disease].

Gastroenterol Hepatol. 2006 May;29(5):321-2. doi: 10.1157/13087475.

Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.

J Crohns Colitis. 2013 Oct;7(9):e397-8. doi: 10.1016/j.crohns.2013.03.003. Epub 2013 Apr 10.

Successful treatment with adalimumab in infliximab-resistant Crohn's disease.

J Gastroenterol Hepatol. 2005 Sep;20(9):1464-5. doi: 10.1111/j.1440-1746.2005.03848.x.

引用本文的文献

Takayasu arteritis in an adolescent with Crohn's disease.

Rheumatol Int. 2022 Mar;42(3):563-570. doi: 10.1007/s00296-021-04869-5. Epub 2021 Apr 27.

Effect of infliximab on inflammatory bowel disease with Takayasu arteritis: case series and review of the literature.

Clin J Gastroenterol. 2013 Jun;6(3):226-30. doi: 10.1007/s12328-013-0387-9. Epub 2013 May 10.

Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Clin Exp Immunol. 2014 Feb;175(2):150-66. doi: 10.1111/cei.12223.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.

作者信息

Calderón R, Estrada S, Ramírez de la Piscina P, Salvador M, Zabaleta S, Enciso C, Delgado E, García-Campos F

出版信息

Rev Esp Enferm Dig. 2010 Feb;102(2):145-6.

PMID:20361852

Abstract

摘要

相似文献

Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.

Rev Esp Enferm Dig. 2010 Feb;102(2):145-6.

Takayasu's aortitis and infliximab.

J Pediatr. 2009 Jul;155(1):151. doi: 10.1016/j.jpeds.2009.01.056.

[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].

Gastroenterol Hepatol. 2014 Jan;37(1):21-2. doi: 10.1016/j.gastrohep.2013.06.008. Epub 2013 Sep 9.

Refractory Takayasu arteritis successfully treated with infliximab.

Eur Rev Med Pharmacol Sci. 2009 Jan-Feb;13(1):63-5.

Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.

Intern Med. 2006;45(5):313-6. doi: 10.2169/internalmedicine.45.1377. Epub 2006 Apr 3.

Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.

Inflamm Bowel Dis. 2009 Oct;15(10):1458-9. doi: 10.1002/ibd.20965.

Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.

Inflamm Bowel Dis. 2009 Oct;15(10):1460-6. doi: 10.1002/ibd.20915.

[Infliximab-induced hepatitis in a patient with Crohn's disease].

Gastroenterol Hepatol. 2006 May;29(5):321-2. doi: 10.1157/13087475.

Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.

J Crohns Colitis. 2013 Oct;7(9):e397-8. doi: 10.1016/j.crohns.2013.03.003. Epub 2013 Apr 10.

Successful treatment with adalimumab in infliximab-resistant Crohn's disease.

J Gastroenterol Hepatol. 2005 Sep;20(9):1464-5. doi: 10.1111/j.1440-1746.2005.03848.x.

引用本文的文献

Takayasu arteritis in an adolescent with Crohn's disease.

Rheumatol Int. 2022 Mar;42(3):563-570. doi: 10.1007/s00296-021-04869-5. Epub 2021 Apr 27.

Effect of infliximab on inflammatory bowel disease with Takayasu arteritis: case series and review of the literature.

Clin J Gastroenterol. 2013 Jun;6(3):226-30. doi: 10.1007/s12328-013-0387-9. Epub 2013 May 10.

Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Clin Exp Immunol. 2014 Feb;175(2):150-66. doi: 10.1111/cei.12223.